ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Charles River Laboratories International (CRL)
Charles River Laboratories International stock price today, ATLAS forecast and fair value
Healthcare · Diagnostics & Research · NYSE
$354.36▲ +2.60%
Prices as of Oct 23, 2026 · USD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Charles River Laboratories International in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Charles River Laboratories International
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Charles River Laboratories International a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $325.47 and $383.12; in 9 out of 10, between $281.67 and $442.70. Estimated annual volatility is 49%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $14.1B
- 52-week high
- $354.36
- 52-week low
- $146.20
- Revenue (12 months)
- $4.0B
- Revenue growth (YoY)
- -0.9%
- Earnings growth (YoY)
- -1,555.0%
- Gross margin
- 33.0%
- Operating margin
- 10.0%
- Net margin
- -3.5%
- Return on equity
- -7.5%
- Free cash flow (12 months)
- $469M
- Beta
- 1.41
What this means
ATLAS does not publish a fair value for CRL right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks CRL has traded between $146.20 and $354.36. Today it is at its high and 142% above its low.
On the business: revenue fell 0.9% year over year; net margin is 3.5%.
Its beta is 1.41: it tends to move more than the market, both up and down.
About the company
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages.
Want to see everything about Charles River Laboratories International?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Charles River Laboratories International do?
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages.
What is the chance CRL goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, CRL ends the month between $325.47 and $383.12.
How big is Charles River Laboratories International and what is its P/E ratio?
Charles River Laboratories International's market capitalization is $14.1B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is CRL?
ATLAS estimates annual volatility at 49%. In a typical month, half of the outcomes end between $325.47 and $383.12.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer